IGKC and breast carcinoma: These investigators identified the immunoglobulin G kappa chain (IGKC) as an immunologic biomarker of prognosis and response to chemotherapy in hundreds of patients with breast cancer, non-small lung cancer, and CRC (Schmidt et al., 2012).